CardioMEMS Implantation Using Gadolinium-based Contrast Agent: A Case Report. 2021

Aniket S Rali, and Lynne W Stevenson, and Sandip K Zalawadiya
Section of Advanced Heart Failure and Transplant Cardiology, Division of Cardiovascular Medicine, Vanderbilt University Medical Center Nashville, TN, US.

A 57-year-old woman with New York Heart Association Class III heart failure requiring multiple hospitalisations over the previous year presented for CardioMEMS implantation. Because of the patient's allergy history of anaphylaxis to iodine-based contrast agent she underwent the device implantation with gadolinium-based contrast agent (Magnevist), which was successful.

UI MeSH Term Description Entries

Related Publications

Aniket S Rali, and Lynne W Stevenson, and Sandip K Zalawadiya
March 2018, The American journal of case reports,
Aniket S Rali, and Lynne W Stevenson, and Sandip K Zalawadiya
March 2018, CNS drugs,
Aniket S Rali, and Lynne W Stevenson, and Sandip K Zalawadiya
April 2022, European heart journal. Case reports,
Aniket S Rali, and Lynne W Stevenson, and Sandip K Zalawadiya
November 2004, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
Aniket S Rali, and Lynne W Stevenson, and Sandip K Zalawadiya
November 2022, Journal of medical case reports,
Aniket S Rali, and Lynne W Stevenson, and Sandip K Zalawadiya
November 2020, Cardiovascular revascularization medicine : including molecular interventions,
Aniket S Rali, and Lynne W Stevenson, and Sandip K Zalawadiya
August 2006, AJNR. American journal of neuroradiology,
Aniket S Rali, and Lynne W Stevenson, and Sandip K Zalawadiya
November 2001, Renal failure,
Aniket S Rali, and Lynne W Stevenson, and Sandip K Zalawadiya
September 2000, Annals of vascular surgery,
Aniket S Rali, and Lynne W Stevenson, and Sandip K Zalawadiya
June 2018, CNS drugs,
Copied contents to your clipboard!